Finance

Lists
300147:SHE
Xiangxue Pharmaceutical Co Ltd
5,14 CN¥
-1,34%
(-0,070) 1D
16-окт., 15:04:58 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300147...
Open
5,11 CN¥
High
5,30 CN¥
Low
5,10 CN¥
Mkt. cap
3,57 млд
Avg. vol.
10,62 млн
Volume
8,21 млн
52-wk high
11,23 CN¥
52-wk low
5,03 CN¥
EPS
-2,16 CN¥
Shares outstanding
661,28 млн
No. of employees
3 миң
Open
5,11 CN¥
High
5,30 CN¥
Low
5,10 CN¥
Mkt. cap
3,57 млд
Avg. vol.
10,62 млн
Volume
8,21 млн
52-wk high
11,23 CN¥
52-wk low
5,03 CN¥
EPS
-2,16 CN¥
Shares outstanding
661,28 млн
No. of employees
3 миң
News stories
From web sources and news partners
Profile
Xiangxue Pharmaceutical Co., Ltd. also known as XPH, is a Chinese pharmaceutical company. It was headquartered in Guangzhou Economic and Technological Development Zone, Guangzhou, the capital of the Guangdong Province. The company started in a place that near to the tourist spot Luogang Xiangxue, thus called itself Xiangxue. Xiangxue Pharmaceutical was a constituent of SZSE 200 Index, but was removed in January 2017; it was inserted to SZSE 700 Index instead at the same time. SZSE 200, 300 and 700 Indexes are subsets of SZSE 1000 Index, the latter is a stock market index for the top 1,000 companies by free-float adjusted capitalization. In July 2017 Xiangxue was also removed from SZSE Component Index, an index for top 500 companies of the exchange. Wikipedia
About Xiangxue Pharmaceutical Co Ltd
CEO-
Employees2,66 миң
Founded1997-ж., 29-дек.
Headquarters-
SectorPharmaceutical industry
Websitexphcn.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
327,92 млн
449,49 млн
354,16 млн
348,62 млн
Cost of goods sold
176,35 млн
388,48 млн
228,49 млн
252,20 млн
Cost of revenue
176,35 млн
388,48 млн
228,49 млн
252,20 млн
Research and development expenses
15,40 млн
22,13 млн
10,74 млн
11,51 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
132,20 млн
75,98 млн
89,74 млн
95,27 млн
Operating expense
153,13 млн
108,42 млн
97,82 млн
111,19 млн
Total operating expenses
329,48 млн
496,91 млн
326,31 млн
363,40 млн
Operating income
-1,56 млн
-47,41 млн
27,85 млн
-14,78 млн
Other non operating income
302,00 миң
-14,25 млн
-944,82 миң
-2,74 млн
EBT including unusual items
-118,29 млн
-1,00 млд
-89,20 млн
-147,88 млн
EBT excluding unusual items
-67,96 млн
-144,93 млн
-40,82 млн
-81,08 млн
Income tax expense
3,13 млн
30,08 млн
9,14 млн
5,48 млн
Effective tax rate
-2,65%
-3,00%
-10,25%
-3,70%
Other operating expenses
3,55 млн
4,05 млн
-3,18 млн
-1,15 млн
Net income
-128,03 млн
-1,03 млд
-111,44 млн
-157,38 млн
Net profit margin
-39,04%
-229,21%
-31,47%
-45,14%
Earnings per share
-
-
-
-
Interest and investment income
-
175,82 миң
23,18 миң
15,53 миң
Interest expense
-66,70 млн
-83,47 млн
-67,75 млн
-63,58 млн
Net interest expenses
-66,70 млн
-83,30 млн
-67,73 млн
-63,56 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
52,99 млн
15,22 миң
75,28 млн
37,21 млн
Gain or loss from assets sale
932,06 миң
-8,92 млн
-
-107,04 миң
AI content may include mistakes. Learn more
Google колдонмолору